Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Global Hyaluronic Acid Market, By Product, By Grade, By Formulation, By Application, By Distribution Channel, By Use, Estimation & Forecast, 2017 - 2030" report has been added to ResearchAndMarkets.com's offering. The global hyaluronic acid market apprehended a market value of USD 7.94 billion in 2021 and is projected to reach USD 20.01 billion by the year 2030. The market is projected to list a CAGR of 11.53% during the forecast period. Moreover, the global hyaluronic acid market volume was 2,156.23 metric tons in 2021. The hyaluronic acid business is likely to grow at a considerable rate owing to the increasing demand at the supply end for anti-aging products, as well as aesthetic therapies. Moreover, the rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. The growing strategic moves by the key players is boosting the market growth. For instance, in February 2017, Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, received approval from the U.S. Food and Drug Administration (FDA) for an expanded 26-week efficacy claim for its single-injection viscosupplement Gel-One Cross-linked Hyaluronate for the treatment of knee pain associated with osteoarthritis. On the other hand, the hyaluronic acid market is projected to get hampered by the high costs associated with the products. Moreover, the side effects and the gray market is estimated to create a level of uncertainty in the marketspace. Growth Influencers:
Increasing Demand for Anti-aging Cosmetics and Aesthetic Treatment The high usage of anti-aging cosmetic products is fueling the growth rate of the global hyaluronic acid market. for instance, according to the Aesthetic Plastic Surgery statistics published in 2020, there were 17.7 million cosmetic procedures done in 2018. Similarly, as per the International Society of Plastic Surgery (ISPAS) statistics in 2019, a total of 1.5 million individuals aged 51-64 years underwent botulinum toxin procedures worldwide in 2019. Such high statistics push towards the rise in market value of the hyaluronic acid market. Increase in usage of Hyaluronic Acid in Osteoarthritis and Dry Eye Hyaluronic acid has several applications, namely, osteoarthritis, dry eye, and dietary supplements and cosmetics. The rising applications of hyaluronic acid in these areas boosts the market value of the market drastically. For instance, according to a study published in Journal of Bone & Joint Surgery. the use of hyaluronic acid injections for knee osteoarthritis in Medicare beneficiaries increased substantially from 2012 to 2018. The increased use of hyaluronic acid products is boosting the growth rate of the market over the forecast period. The global hyaluronic acid market report provides insights on the below pointers:
Market Penetration: Provides comprehensive information on the market offered by the prominent players
Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the global hyaluronic acid market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
Pricing Analysis: Pricing analysis of various metals and other components used in the manufacturing of hyaluronic acid products
Manufacturing Cost Analysis: Cost-share of various components in hyaluronic acid products, cost analysis, unit cost analysis
The global hyaluronic acid market report answers questions such as:
What is the market size and forecast of the global hyaluronic acid market?
What are the inhibiting factors and impact of COVID-19 on the global hyaluronic acid market during the assessment period?
Which are the types/segments/applications/areas to invest in over the assessment period in the global hyaluronic acid market?
What is the competitive strategic window for opportunities in the global hyaluronic acid market?
What are the technology trends and regulatory frameworks in the global hyaluronic acid market?
What is the market share of the leading players in the global hyaluronic acid market?
What modes and strategic moves are considered favorable for entering the global hyaluronic acid market?
Key Topics Covered: Part 1 Market Definition and Research Methodology
Part 2 Executive Summary Part 3 Market Dynamics
Porter's Five Forces Analysis
Fidia Farmaceutici s.p.a
Part 6 Global Hyaluronic Acid Market
Market Overview - Market Size (2020-2030)
Pills, 2020-2030 (in USD Billion & Metric Ton)
Liquid, 2020-2030 (in USD Billion & Metric Ton)
Injection, 2020-2030 (in USD Billion & Metric Ton)
Single Cycle Injection, 2020-2030 (in USD Billion & Metric Ton)
Three Cycle Injection, 2020-2030 (in USD Billion & Metric Ton)
Five Cycle Injection, 2020-2030 (in USD Billion & Metric Ton)
Powder, 2020-2030 (in USD Billion & Metric Ton)
Others, 2020-2030 (in USD Billion & Metric Ton)
Medical Grade, 2020-2030 (in USD Billion & Metric Ton)
Food Grade, 2020-2030 (in USD Billion & Metric Ton)
Cosmetic Grade, 2020-2030 (in USD Billion & Metric Ton)
HA + Lidocaine, 2020-2030 (in USD Billion & Metric Ton)
HA, 2020-2030 (in USD Billion & Metric Ton)
Aesthetics, 2020-2030 (in USD Billion & Metric Ton)
Osteoarthristis, 2020-2030 (in USD Billion & Metric Ton)
Pharmaceutical API, 2020-2030 (in USD Billion & Metric Ton)
Cosmetics, 2020-2030 (in USD Billion & Metric Ton)
Dietary Supplement, 2020-2030 (in USD Billion & Metric Ton)
Opthalmology, 2020-2030 (in USD Billion & Metric Ton)
Others, 2020-2030 (in USD Billion & Metric Ton)
Hospitals, 2020-2030 (in USD Billion & Metric Ton)
Specialty Clinics, 2020-2030 (in USD Billion & Metric Ton)
Retail Pharmacies, 2020-2030 (in USD Billion & Metric Ton)
Online Pharmacies, 2020-2030 (in USD Billion & Metric Ton)
Medical Use, 2020-2030 (in USD Billion & Metric Ton)
Non-Medical Use, 2020-2030 (in USD Billion & Metric Ton)
North America, 2020-2030 (in USD Billion)
Europe, 2020-2030 (in USD Billion)
Asia Pacific, 2020-2030 (in USD Billion)
Latin America, 2020-2030 (in USD Billion)
Middle East and Africa, 2020-2030 (in USD Billion)
Part 7 North America Hyaluronic Acid Market
Part 8 Europe Hyaluronic Acid Market
Part 9 Asia Pacific Hyaluronic Acid Market
Part 10 Latin America Hyaluronic Acid Market
Part 11 Middle East & Africa Hyaluronic Acid Market
Medical Grade, 2020-2030 (in USD Billion & Metric Ton)
Food Grade, 2020-2030 (in USD Billion & Metric Ton)
Cosmetic Grade, 2020-2030 (in USD Billion & Metric Ton)
HA + Lidocaine, 2020-2030 (in USD Billion & Metric Ton)
HA, 2020-2030 (in USD Billion & Metric Ton)
Medical Grade, 2020-2030 (in USD Billion & Metric Ton)
Food Grade, 2020-2030 (in USD Billion & Metric Ton)
Cosmetic Grade, 2020-2030 (in USD Billion & Metric Ton)
HA + Lidocaine, 2020-2030 (in USD Billion & Metric Ton)
HA, 2020-2030 (in USD Billion & Metric Ton)
Aesthetics, 2020-2030 (in USD Billion & Metric Ton)
Osteoarthristis, 2020-2030 (in USD Billion & Metric Ton)
Pharmaceutical API, 2020-2030 (in USD Billion & Metric Ton)
Cosmetics, 2020-2030 (in USD Billion & Metric Ton)
Dietary Supplement, 2020-2030 (in USD Billion & Metric Ton)
Opthalmology, 2020-2030 (in USD Billion & Metric Ton)
Others, 2020-2030 (in USD Billion & Metric Ton)
Hospitals, 2020-2030 (in USD Billion & Metric Ton)
Specialty Clinics, 2020-2030 (in USD Billion & Metric Ton)
Retail Pharmacies, 2020-2030 (in USD Billion & Metric Ton)
Online Pharmacies, 2020-2030 (in USD Billion & Metric Ton)
Medical Use, 2020-2030 (in USD Billion & Metric Ton)
Non-Medical Use, 2020-2030 (in USD Billion & Metric Ton)
UAE, 2020-2030 (in USD Billion & Metric Ton)
Saudi Arabia, 2020-2030 (in USD Billion & Metric Ton)
South Africa, 2020-2030 (in USD Billion & Metric Ton)
Rest of Middle East & Africa, 2020-2030 (in USD Billion & Metric Ton)
For more information about this report visit https://www.researchandmarkets.com/r/nz3fl9
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Q.: My wife inherited a 401(k) from my mom who died recently. Assuming this is a traditional 401(k), you are correct that whatever comes out of the account will be likely be taxable to you. Transfer your wife’s share of the money to an Inherited 401(k) with the company that held your mom’s 401(k).
VistaGen Therapeutics Inc (NASDAQ: VTGN) has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for the acute treatment of social anxiety disorder. PH94B did not achieve its primary endpoint, as measured by change from baseline using the Subjective Units of Distress Scale (SUDS) compared to placebo. SUDS rating scale is used to measure the intensity of distress or nervousness in people with social anxiety. Social anxiety disorder affects an estimated 25 million Americans. Altho
Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.
Yahoo Finance's Brian Cheung and Akiko Fujita discuss Snap earnings and analyst reratings on the stock.
Yahoo Finance's Ines Ferré breaks down how stocks are trading on Friday afternoon as the Nasdaq lags following Snap earnings.
Fewer are reverting to traditional office jobs, with a growing number seeking nontraditional roles, or even the opportunity to start a new business.
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
Novavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first commercial product. But the company is still working on younger age group eligibility and boosters with the FDA.
Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.
IBM (IBM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).
Yahoo Finance anchors discuss three other business stories, including Buzz Aldrin auctioning off his moon landing jacket, Tesla getting its own lane at the Mexican border, and Disney adding R-rated movies to its streaming service.
We’re supposed to be energy independent. What gives?
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Jim Cramer is a lightning rod when it comes to scrutiny. On one hand, giving investing advice every day on air for years is naturally going to produce some losing picks. However, Cramer has become the focal point of a lot of targeted opposition. For instance, you can check out his ongoing (albeit one-sided) feud with George Noble, who is quick to call out Cramer. Or, you could check out the Journal of Retirement’s in-depth study of Cramer’s Charitable Trust performance and see that “Cramer’s por
When a company creates a significant amount of value over the long term, its stock price generally delivers strong gains. To bring their shares back into easier reach for retail investors, companies can conduct stock splits, and in 2022, a host of big technology companies are doing just that. Google parent Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) was the most recent.
Yahoo Finance Live's Rachelle Akuffo, Seana Smith, and Dave Briggs look at several of today's trending stocks.